triazoles has been researched along with Brain Diseases in 35 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (2.86) | 18.7374 |
| 1990's | 4 (11.43) | 18.2507 |
| 2000's | 14 (40.00) | 29.6817 |
| 2010's | 15 (42.86) | 24.3611 |
| 2020's | 1 (2.86) | 2.80 |
| Authors | Studies |
|---|---|
| Chegini, Z; Didehdar, M; Khoshbayan, A; Rajaeih, S; Salehi, M; Shariati, A | 1 |
| Foolad, F; Kontoyiannis, DP | 1 |
| Baker, EM; George, AL; Hawkins, NA; Kearney, JA; Meisler, MH; Patel, MK; Thompson, CH; Wagnon, JL; Wengert, ER | 1 |
| Abdolalizadeh, P; Ghazizadeh, M; Hadi, Y; Karimi, N; Kashkouli, MB; Oghazian, M | 1 |
| Chien, HC; Colas, C; Giacomini, KM; Hall, C; Schlessinger, A; Thomas, AA; Wells, A; Wolfe, H | 1 |
| Ervens, J; Ghannoum, M; Graf, B; Schwartz, S | 1 |
| Kohn, R; Kotton, CN; Markmann, JF; Patel, MS; Vagefi, PA; Wright, AJ | 1 |
| Garvey, LJ; Mora-Peris, B; Scott, J; Underwood, J; Winston, A | 1 |
| John, AO; Manesh, A; Mathew, B; Rupa, V; Varghese, GM; Varghese, L; Zachariah, A | 1 |
| Adegbola, SO; Banerjee, A; Mulcahy, MP | 1 |
| Hiraga, A; Kamitsukasa, I; Numata, T; Shibuya, M; Sunami, S; Uzawa, A | 1 |
| Butler, C; Clarke, P; Habibi, M; Howard, D; Kulendra, K | 1 |
| Balestri, A; Coppola, G; Curatolo, P; D'Aniello, A; Fels, A; Franzoni, E; Grosso, S; Habetswallner, F; Mangano, S; Parisi, P; Pascotto, A; Spalice, A; Veggiotti, P; Verrotti, A; Zamponi, N | 1 |
| Khera, S; Rustagi, T; Uy, EM | 1 |
| DiBartolo, MA; Kelley, PS | 1 |
| Arda, B; Ceylan, N; Erdem, A; Işıkgöz Taşbakan, M; Metin, DY; Midilli, R; Pullukçu, H; Sipahi, OR; Taşbakan, MS; Ulusoy, S; Yamazhan, T | 1 |
| Goel, RS; Gupta, A; Jain, A; Kataria, R; Singh, S; Sinha, VD | 1 |
| Abu El-Naaj, I; Leiser, Y; Peled, M; Wolff, A | 1 |
| Belmatoug, N; de Lastours, V; Dufour, V; Fantin, B; Lefort, A; Zappa, M | 1 |
| Giles, SS; Kurtzberg, J; Perfect, JR; Schell, WA; Steinbach, WJ; Trinh, JV | 1 |
| Bethell, D; Goodman, TR; Hall, G; Klein, N; Pollard, AJ | 1 |
| Bruneel, F; Chevret, S; de Broucker, T; Lellouche, F; Régnier, B; Tattevin, P; Wolff, M | 1 |
| Al-Abdely, HM; Al-Tawfiq, JA; Alkhunaizi, AM; Hassounah, M; Rinaldi, MG; Sutton, DA | 1 |
| Aksamit, AJ; Bakleh, M; Marshall, WF; Tleyjeh, IM | 1 |
| Bedini, A; Cocchi, S; Codeluppi, M; Esposito, R; Guaraldi, G; Squillace, N; Venturelli, C | 1 |
| Edwards, C; Garcia, RJ; Troya, P | 1 |
| Borgia, SM; El-Helou, P; Fuller, JD; Sarabia, A | 1 |
| Fatokun, AA; Smith, RA; Stone, TW | 1 |
| Hampton, T | 1 |
| Hata, K; Katsu, K; Kimura, J; Miki, H; Moriyama, M; Toyosawa, T | 1 |
| Fenu, S; Morelli, M; Ongini, E; Pinna, A | 1 |
| Milatovic, D; Schwartz, S; Thiel, E | 1 |
| Crain, BJ; Nadler, JV; Warner, MA | 1 |
| Andrews, RJ; Marriott, MS; Richardson, K; Troke, PF | 1 |
3 review(s) available for triazoles and Brain Diseases
| Article | Year |
|---|---|
Epidemiology, clinical features, diagnosis and treatment of cerebral mucormycosis in diabetic patients: A systematic review of case reports and case series.
Topics: Amphotericin B; Antifungal Agents; Brain Diseases; Deoxycholic Acid; Diabetes Complications; Diabetes Mellitus; Drug Combinations; Humans; Mucormycosis; Risk Factors; Triazoles | 2020 |
Successful therapy of cerebral phaeohyphomycosis due to Ramichloridium mackenziei with the new triazole posaconazole.
Topics: Antifungal Agents; Ascomycota; Brain Diseases; Central Nervous System Fungal Infections; Humans; Male; Middle Aged; Mycoses; Treatment Outcome; Triazoles | 2005 |
Invasive aspergillosis with central nervous system dissemination in a presumably immunocompetent, non-neutropenic patient: case report and review.
Topics: Antifungal Agents; Aspergillosis; Brain Diseases; Humans; Immunocompetence; Lung Diseases, Fungal; Magnetic Resonance Imaging; Male; Middle Aged; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2006 |
1 trial(s) available for triazoles and Brain Diseases
| Article | Year |
|---|---|
Rufinamide in refractory childhood epileptic encephalopathies other than Lennox-Gastaut syndrome.
Topics: Adolescent; Adult; Anticonvulsants; Brain Diseases; Child; Child, Preschool; Epilepsy; Female; Humans; Male; Triazoles; Young Adult | 2011 |
31 other study(ies) available for triazoles and Brain Diseases
| Article | Year |
|---|---|
Persistent CNS toxicity in a patient receiving posaconazole tablets after discontinuation of voriconazole due to supratherapeutic serum levels.
Topics: Antifungal Agents; Brain Diseases; Humans; Male; Middle Aged; Serum; Tablets; Triazoles; Voriconazole | 2018 |
The novel sodium channel modulator GS-458967 (GS967) is an effective treatment in a mouse model of SCN8A encephalopathy.
Topics: Action Potentials; Animals; Anticonvulsants; Brain Diseases; Disease Models, Animal; Drug Administration Schedule; Electroshock; Epilepsy; Female; Hippocampus; Humans; Male; Mice; Mice, Transgenic; Mutation; NAV1.6 Voltage-Gated Sodium Channel; Neurons; Off-Label Use; Phenytoin; Pyridines; Triazoles | 2018 |
Outcomes and factors affecting them in patients with rhino-orbito-cerebral mucormycosis.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Brain Diseases; Combined Modality Therapy; Debridement; Deoxycholic Acid; Eye Infections, Fungal; Female; Humans; Male; Middle Aged; Mucormycosis; Natural Orifice Endoscopic Surgery; Orbital Diseases; Paranasal Sinus Diseases; Retrospective Studies; Treatment Outcome; Triazoles; Young Adult | 2019 |
l-Type amino acid transporter 1 activity of 1,2,3-triazolyl analogs of l-histidine and l-tryptophan.
Topics: Antineoplastic Agents; Brain Diseases; Click Chemistry; Dose-Response Relationship, Drug; Histidine; Humans; Large Neutral Amino Acid-Transporter 1; Molecular Structure; Neoplasms; Prodrugs; Structure-Activity Relationship; Triazoles; Tryptophan | 2019 |
Successful isavuconazole salvage therapy in a patient with invasive mucormycosis.
Topics: Antifungal Agents; Brain Diseases; Humans; Male; Middle Aged; Mucormycosis; Nitriles; Pyridines; Rhizopus; Salvage Therapy; Treatment Outcome; Triazoles | 2014 |
Successful long-term management of invasive cerebral fungal infection following liver transplantation.
Topics: Antifungal Agents; Aspergillus; Aspergillus flavus; Brain Diseases; Central Nervous System Fungal Infections; Drug Therapy, Combination; Humans; Liver Transplantation; Male; Middle Aged; Neuroaspergillosis; Radiography; Scedosporium; Triazoles; Voriconazole | 2015 |
A comparison of two post-processing analysis methods to quantify cerebral metabolites measured via proton magnetic resonance spectroscopy in HIV disease.
Topics: Biomarkers; Brain; Brain Diseases; CCR5 Receptor Antagonists; Cyclohexanes; HIV Infections; Humans; Maraviroc; Proton Magnetic Resonance Spectroscopy; Triazoles | 2016 |
Posaconazole: an emerging therapeutic option for invasive rhino-orbito-cerebral mucormycosis.
Topics: Adult; Antifungal Agents; Brain Diseases; Female; Humans; Male; Middle Aged; Mucorales; Mucormycosis; Nose Diseases; Orbital Diseases; Retrospective Studies; Triazoles; Young Adult | 2016 |
Rhinocerebral mucormycosis.
Topics: Aged; Antifungal Agents; Brain Diseases; Diabetes Complications; Fatal Outcome; Female; Humans; Mucormycosis; Nose Diseases; Triazoles | 2009 |
Neuroaspergillosis in an immunocompetent patient successfully treated with voriconazole and a corticosteroid.
Topics: Aged; Antifungal Agents; Brain Diseases; Humans; Immunocompetence; Male; Neuroaspergillosis; Pyrimidines; Remission Induction; Triazoles; Voriconazole | 2009 |
Use of posaconazole in the treatment of infective rhinocerebral mucormycosis.
Topics: Antifungal Agents; Brain Diseases; Diabetes Mellitus, Type 2; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Mucormycosis; Orbital Diseases; Paranasal Sinus Diseases; Rhizopus; Triazoles | 2010 |
Cerebral mucormycosis in a diabetic man.
Topics: Amphotericin B; Antifungal Agents; Biopsy; Brain Diseases; Combined Modality Therapy; Diabetes Mellitus, Type 2; Diagnosis, Differential; Drug Therapy, Combination; Endoscopy; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Mucormycosis; Tomography, X-Ray Computed; Triazoles | 2011 |
Rhino-orbital-cerebral mucormycosis (ROCM): a comprehensive case review.
Topics: Adult; Amphotericin B; Antifungal Agents; Brain Diseases; Debridement; Diabetes Insipidus, Nephrogenic; Diabetes Mellitus, Type 1; Disease Progression; Eye Infections, Fungal; Humans; Immunocompromised Host; Magnetic Resonance Imaging; Male; Mucormycosis; Nose Diseases; Orbital Diseases; Tomography, X-Ray Computed; Triazoles | 2011 |
[Mucormycosis: retrospective evaluation of 12 cases].
Topics: Adolescent; Adult; Aged; Antifungal Agents; Brain Diseases; Diabetes Complications; Female; Hematologic Diseases; Humans; Lung Diseases, Fungal; Male; Middle Aged; Mucormycosis; Nose Diseases; Orbital Diseases; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole; Young Adult | 2011 |
Craniocerebral maduromycosis.
Topics: Adolescent; Antifungal Agents; Bone Diseases; Brain Diseases; Female; Humans; India; Madurella; Magnetic Resonance Imaging; Mycetoma; Naphthalenes; Parietal Lobe; Pyrimidines; Scalp; Seizures; Terbinafine; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2012 |
The surgical management of rhinocerebral mucormycosis.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Brain Diseases; Cause of Death; Combined Modality Therapy; Diagnosis, Differential; Fatal Outcome; Female; Hematologic Neoplasms; Humans; Immunocompromised Host; Male; Maxillary Sinusitis; Middle Aged; Mucormycosis; Nose Diseases; Paranasal Sinus Diseases; Pyrimidines; Triazoles; Voriconazole; Young Adult | 2013 |
[New onset headache. Which patients should be sent for CT imaging?].
Topics: Acute Disease; Brain Diseases; Diagnosis, Differential; Drug Administration Schedule; Headache; Humans; Migraine Disorders; Tomography, X-Ray Computed; Triazoles; Tryptamines | 2002 |
Two cases of cerebral aspergillosis successfully treated with voriconazole.
Topics: Administration, Oral; Antifungal Agents; Brain Diseases; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Magnetic Resonance Imaging; Male; Middle Aged; Neuroaspergillosis; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2003 |
Cerebral phaeohyphomycosis in an immunodeficient child treated medically with combination antifungal therapy.
Topics: Anti-Bacterial Agents; Antifungal Agents; Ascomycota; Brain Abscess; Brain Diseases; Caspofungin; Child; Drug Therapy, Combination; Echinocandins; Fatal Outcome; Humans; Immunologic Deficiency Syndromes; Lipopeptides; Male; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2003 |
Resolution of orbitocerebral aspergillosis during combination treatment with voriconazole and amphotericin plus adjunctive cytokine therapy.
Topics: Amphotericin B; Antifungal Agents; Blindness; Brain Diseases; Child, Preschool; Cytokines; Drug Therapy, Combination; Female; Humans; Neuroaspergillosis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Remission Induction; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole | 2004 |
Successful treatment of brain aspergillosis with voriconazole.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillus; Brain Diseases; Critical Care; Female; Humans; Immunocompromised Host; Male; Middle Aged; Neuroaspergillosis; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2004 |
Successful treatment of cerebral blastomycosis with voriconazole.
Topics: Antifungal Agents; Blastomycosis; Brain Diseases; Female; Humans; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2005 |
Invasive pulmonary and cerebral aspergillosis in a patient with Weil's disease.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Brain Diseases; Drug Therapy, Combination; Humans; Lung Diseases, Fungal; Male; Middle Aged; Pyrimidines; Radiography; Treatment Outcome; Triazoles; Voriconazole; Weil Disease | 2005 |
Cerebral blastomycosis: a case series incorporating voriconazole in the treatment regimen.
Topics: Adult; Antifungal Agents; Blastomycosis; Brain Diseases; Central Nervous System Fungal Infections; Humans; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2006 |
Cell death in rat cerebellar granule neurons induced by hydrogen peroxide in vitro: mechanisms and protection by adenosine receptor ligands.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A2 Receptor Antagonists; Animals; Animals, Newborn; Apoptosis; Brain Diseases; Catalase; Cell Death; Cell Survival; Cells, Cultured; Cerebellar Cortex; Dose-Response Relationship, Drug; Enzyme Inhibitors; Hydrogen Peroxide; Necrosis; Neurons; Oxidative Stress; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A1; Receptors, Adenosine A2; Receptors, Purinergic P1; Time Factors; Triazines; Triazoles | 2007 |
Strides made in red blood cell disorders, but substantial barriers to care remain.
Topics: Anemia, Sickle Cell; Antisickling Agents; Benzoates; Brain Diseases; Chelation Therapy; Deferasirox; Hematologic Diseases; Hematology; Humans; Hydroxyurea; Iron Chelating Agents; Triazoles | 2008 |
Efficacy of ER-30346, a novel oral triazole antifungal agent, in experimental models of aspergillosis, candidiasis, and cryptococcosis.
Topics: Animals; Antifungal Agents; Aspergillosis; Brain Diseases; Candidiasis; Candidiasis, Oral; Cryptococcosis; Female; Fluconazole; Lung Diseases, Fungal; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Rats; Rats, Sprague-Dawley; Thiazoles; Triazoles | 1996 |
Adenosine A2A receptor antagonism potentiates L-DOPA-induced turning behaviour and c-fos expression in 6-hydroxydopamine-lesioned rats.
Topics: Animals; Behavior, Animal; Brain Diseases; Dopamine Agonists; Drug Synergism; Gene Expression; Genes, fos; Levodopa; Male; Oxidopamine; Proto-Oncogene Proteins c-fos; Purinergic P1 Receptor Antagonists; Pyrimidines; Quinpirole; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A; Receptors, Dopamine D2; Substantia Nigra; Triazoles | 1997 |
Successful treatment of cerebral aspergillosis with a novel triazole (voriconazole) in a patient with acute leukaemia.
Topics: Acute Disease; Adolescent; Antifungal Agents; Aspergillosis; Brain Diseases; Humans; Leukemia; Male; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole | 1997 |
Effects of NMDA receptor antagonists and body temperature in the gerbil carotid occlusion model of transient forebrain ischemia.
Topics: Animals; Anticonvulsants; Body Temperature; Brain; Brain Diseases; Carotid Arteries; Corpus Striatum; Disease Models, Animal; Dizocilpine Maleate; Gerbillinae; Hippocampus; Hypothermia; Ischemic Attack, Transient; Male; Pipecolic Acids; Pyramidal Tracts; Receptors, N-Methyl-D-Aspartate; Triazoles | 1990 |
Efficacy of fluconazole (UK-49,858) against experimental aspergillosis and cryptococcosis in mice.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus flavus; Aspergillus fumigatus; Brain Diseases; Cryptococcosis; Female; Fluconazole; Ketoconazole; Lung Diseases, Fungal; Mice; Opportunistic Infections; Triazoles | 1987 |